TCL Archive Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression November 30, 2012
TCL Archive Clinical Trial Pathology Improvements Recommended By Group Remaining Actions After Merit Review January 12, 1979